The AI-Mind project made a significant impact during the 34th Alzheimer Europe Conference, held from 8-10 October in Geneva (Switzerland), by unveiling its latest research findings. This milestone marked a key moment for the project, which focused on developing Artificial Intelligence digital tools for screening brain connectivity and dementia risk estimation. These tools aim to support healthcare professionals in their diagnosis and enable them to predict which people with Mild Cognitive Impairment (MCI) are likely to develop dementia. A major highlight was the participation of AI-Mind’s project coordinator, Dr Ira Haraldsen, taking the stage as a keynote speaker in the final plenary session on brain health and prevention. She highlighted the innovative potential of artificial intelligence in dementia research, particularly in risk prediction and early diagnosis, signaling promising advancements for the future.
Throughout the conference, members of the AI-Mind Consortium showcased their groundbreaking research through several oral presentations. As the AI-Mind project continues to advance the field of artificial intelligence in dementia prevention, the consortium looks forward to reconvening in Madrid at the end of October for its Project General Assembly Meeting. Additionally, members will continue to disseminate their findings at conferences such as the upcoming 17th Clinical Trials on Alzheimer’s Disease (CTAD) to be held on 29 October – 1 November.
https://www.ai-mind.eu/blog/ai-mind-presents-results-at-alzheimer-europe-conference-in-geneva/
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220.
